Geron Corporation - Common Stock — Stato Patrimoniale (NASDAQ:GERN)

Financials

Totale attivo 270.73 M226.03 M190.57 M394.08 M593.78 M570.54 M Totale passività 59.78 M99.62 M110.58 M146.13 M313.46 M344.67 M Patrimonio netto totale 210.95 M126.42 M80 M247.95 M280.32 M225.87 M Totale passività e patrimonio netto 270.73 M226.03 M190.57 M394.08 M593.78 M570.54 M Debito totale 24.04 M49.83 M51.16 M81.94 M165.37 M119.55 M Indebitamento netto 24.04 M49.83 M51.16 M81.94 M165.37 M41.99 M

Geron Corporation - Common Stock

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

GERN

Financials

Geron Corporation - Common Stock

Notizie

Geron (GERN) Loses 21.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Geron Corporation (GERN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Relazione sugli utili Geron Q1 2026: ricavi in crescita, titolo in rialzo

Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates

Geron nomina Timothy Williams chief legal officer

I modelli Fair Value di InvestingPro individuano un guadagno del 53% in Geron Corporation

Geron nomina Patricia S. Andrews e Constantine Chinoporos nel consiglio di amministrazione

Geron aggiunge due amministratori con esperienza commerciale al CdA

Geron alla conferenza Barclays Healthcare: crescita strategica e piani futuri

Geron at Barclays Healthcare Conference: Strategic Growth and Future Plans

Geron Corporation (GERN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?